Russell Frank Company’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$6.05M Sell
210,697
-40,399
-16% -$1.08M 0.01% 1220
2015
Q4
$8.44M Sell
251,096
-1,450
-0.6% -$45.1K 0.01% 972
2015
Q3
$7.18M Sell
252,546
-157,909
-38% -$5.51M 0.01% 1065
2015
Q2
$16.6M Sell
410,455
-132,106
-24% -$5.93M 0.03% 714
2015
Q1
$26.7M Buy
542,561
+168,862
+45% +$7.82M 0.05% 444
2014
Q4
$16.7M Buy
+373,699
New +$14.7M 0.03% 641

Other funds holding AVNS

Russell Frank Company's AVNS Position: Q1 2016 in Review

Russell Frank Company reduced its Avanos Medical (AVNS) stake by 16% in Q1 2016, selling an estimated $1.08M and leaving 210,697 shares worth $6.05M. The position accounts for 0.01% of the portfolio, ranked #1220.

Russell Frank Company first reported a position in AVNS in Q4 2014 and has held it in 6 quarters since. The position peaked at $26.7M in Q1 2015. 332 funds tracked by Wall St. Rank hold AVNS as of Q1 2016.

  • Russell Frank Company held 210,697 shares of Avanos Medical worth $6.05M as of Q1 2016.
  • Russell Frank Company sold 40,399 Avanos Medical shares in Q1 2016, an estimated $1.08M.
  • Avanos Medical made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1220 holding.
  • Russell Frank Company first reported a position in Avanos Medical in Q4 2014 and has held it in 6 quarters since.
  • Russell Frank Company's Avanos Medical position peaked at $26.7M in Q1 2015.
  • 332 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.